Drug Safety and the Public Consciousness
The public consciousness has been flooded with awareness of the previously niche concerns of quality control in drug manufacturing.
Biologics are changing our world. How can we speed up their development?
The global pandemic is shining a spotlight on the power of biologics, both vaccines and antibody therapeutics, to prevent serious infections and treat disease.
The Importance of Digitization in Biopharma
Automation in a vaccine lab is not enough The ultimate goal in the biopharma space, especially for vaccine manufacturers, is producing safe and effective therapies faster, and at a lower cost. Many professionals still believe that their competitive edge relies on…
Powerful software can help biotech companies through the COVID-19 pandemic
In response to the outbreak, governments around the world have put strict measures in place to limit the spread of the virus – Italy was the first country to order a country-wide lock down, France closed its borders and PM…
Addressing the challenges of advanced therapy R&D
In recent years, gene therapies, gene-modified cell therapies and cell therapies, collectively known as ‘Advanced Therapies’, have rapidly become an integral part of the R&D programs of many Biopharmaceutical companies. This is illustrated by some of the key trends and…
Where east meets west – the future of CROs
Western CROs continue to up their game. They are offering unique services in a marketplace where the big CROs of the east are providing an unsurpassed scale of resourcing to support the externalization of discovery services. I believe there is…
i3 Nashville secrets for i3 London
Want to know a secret? In September we hosted a very large group of IDBS customers from the US at i3 Nashville. Customers from every R&D industry sharing experiences, lessons learned, and business challenges. So, are you going to i3…
What i3 Means to Us – Part 4
We sat down with Chelsea Hyde, Field Marketing Manager for North America at IDBS, to find out what i3 means to IDBS, and what to expect at future events. What does i3 mean? When we were coming up with…
What i3 Means to Us – Part 3
We sat down with Christian Marcazzo, General Manager at IDBS, to find out what the benefits of attending i3 are, and how it fits into his vision for IDBS. What are some of the benefits to customers attending the i3…
Biopharma in 2019: the top trends of the year
The biopharmaceutical industry continues to grow and isn’t showing any signs of slowing down. Last year, we talked about different aspects of the biopharmaceutical industry. These touched on several trends from the importance of data and the extensive use of…
